Servus begins fiscal year with strong financial performance and growth
March 27, 2024 09:56 ET
|
Servus Credit Union
Servus Credit Union continued its strong growth trend with assets reaching $20.6 billion, up $1.8 billion (9.8%), compared to the first quarter of 2023.
Sunlands Technology Group Announces Unaudited Fourth Quarter and Full Year 2023 Financial Results
March 22, 2024 04:30 ET
|
Sunlands Technology Group
BEIJING, March 22, 2024 (GLOBE NEWSWIRE) -- Sunlands Technology Group (NYSE: STG) (“Sunlands” or the “Company”), a leader in China’s online post-secondary and professional education, today announced...
Celcuity Inc. Schedules Release of Fourth Quarter and Full Year 2023 Financial Results and Webcast/Conference Call
March 20, 2024 07:05 ET
|
Celcuity Inc.
MINNEAPOLIS, March 20, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it...
BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
March 20, 2024 06:15 ET
|
BioNTech SE
Advanced oncology pipeline in mid- and late-stage with plans to have ten or more potentially registrational oncology trials running by the end of 2024Aiming for first oncology launch in 2026 and...
BioNTech veröffentlicht Ergebnisse für das vierte Quartal und das Geschäftsjahr 2023 sowie Informationen zur Geschäftsentwicklung
March 20, 2024 06:15 ET
|
BioNTech SE
Onkologie-Pipeline weiterentwickelt mit Kandidaten im mittleren und fortgeschrittenem Entwicklungsstadium; BioNTech plant mit zehn oder mehr laufenden potenziell zulassungsrelevanten Studien bis Ende...
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
March 14, 2024 16:39 ET
|
CytoSorbents
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results
VitalHub Announces Q4 2023 Conference Call Date
March 14, 2024 07:30 ET
|
VitalHub Corp.
TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX:VHIBF) is pleased to announce that it will release its financial results for its quarter...
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
March 14, 2024 07:00 ET
|
AC Immune SA
AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update ACI-24.060 ABATE Phase 2 trial to report Abeta-PET imaging results in Q2 and H2ACI-7104.056 VacSYn Phase 2 trial in...
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Results
March 13, 2024 16:05 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., March 13, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing...
HOOPP delivers 9.38% return in 2023: success bolstered by strong Canadian portfolio
March 13, 2024 07:00 ET
|
Healthcare of Ontario Pension Plan
TORONTO, March 13, 2024 (GLOBE NEWSWIRE) -- The Healthcare of Ontario Pension Plan (HOOPP) announced today that it delivered a 9.38% return in 2023, bringing its net assets to $112.6 billion, up...